X-ray absorption and diffraction studies of the metal binding sites in amyloid β-peptide

No abstract is available for this paper.

• Publication year

  2008

• Venue

  European Biophysics Journal

• Publication date

  2008-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s00249-007-0232-5
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42.

  2008cited by this paper
• Metal Ions in Life Sciences

  2007cited by this paper
• Redox Reactions of Copper Complexes Formed with Different β-Amyloid Peptides and Their Neuropathalogical Relevance†

  2007influential reference
• Role of aspartate-1 in Cu(II) binding to the amyloid-beta peptide of Alzheimer's disease.

  2007influential reference
• Engineering metal ion coordination to regulate amyloid fibril assembly and toxicity

  2007influential reference
• Aβ Produced as a Fusion to Maltose Binding Protein Can Be Readily Purified and Stably Associates with Copper and Zinc

  2007cited by this paper
• Redox Chemistry of Copper–Amyloid‐β: The Generation of Hydroxyl Radical in the Presence of Ascorbate is Linked to Redox‐Potentials and Aggregation State

  2007cited by this paper
• Molecular basis for passive immunotherapy of Alzheimer's disease

  2007influential reference
• Atomic structures of amyloid cross-β spines reveal varied steric zippers

  2007cited by this paper
• Metal binding in amyloid β-peptides shows intra- and inter-peptide coordination modes

  2006influential reference
• Structural Changes of Region 1-16 of the Alzheimer Disease Amyloid β-Peptide upon Zinc Binding and in Vitro Aging*

  2006cited by this paper
• Recent atomic models of amyloid fibril structure.

  2006cited by this paper
• Copper-mediated Amyloid-β Toxicity Is Associated with an Intermolecular Histidine Bridge*

  2006influential reference
• NMR reveals anomalous copper(II) binding to the amyloid Abeta peptide of Alzheimer's disease.

  2006cited by this paper
• Structural and thermodynamical properties of CuII amyloid-β16/28 complexes associated with Alzheimer’s disease

  2006cited by this paper
• Probing the influence of X-rays on aqueous copper solutions using time-resolved in situ combined video/X-ray absorption near-edge/ultraviolet-visible spectroscopy.

  2006cited by this paper
• Characterization of copper binding to the peptide amyloid‐β(1–16) associated with Alzheimer's disease

  2006cited by this paper
• Inhibitors of amyloid toxicity based on beta-sheet packing of Abeta40 and Abeta42.

  2006influential reference
• Structural models of amyloid-like fibrils.

  2006cited by this paper
• Beta-structures in fibrous proteins.

  2006cited by this paper
• The structural biology of protein aggregation diseases: Fundamental questions and some answers.

  2006cited by this paper
• Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism

  2006influential reference
• Preparation of amyloid β-protein for structural and functional studies

  2006cited by this paper
• Structure of amyloid β fragments in aqueous environments

  2006influential reference
• The Role of Metal Ions in Neurology. An Introduction

  2006cited by this paper
• 3D structure of Alzheimer's amyloid-β(1–42) fibrils

  2005cited by this paper
• Characterization of chemical exchange between soluble and aggregated states of beta-amyloid by solution-state NMR upon variation of salt conditions.

  2005cited by this paper
• Structure of the cross-beta spine of amyloid-like fibrils.

  2005influential reference
• Self-Propagating, Molecular-Level Polymorphism in Alzheimer's ß-Amyloid Fibrils

  2005influential reference
• Detection, identification and mapping of iron anomalies in brain tissue using X-ray absorption spectroscopy

  2005cited by this paper
• Three-dimensional structure determination using multiple-scattering analysis of XAFS: applications to metalloproteins and coordination chemistry

  2005cited by this paper
• Synchrotron radiation effects on catalytic systems as probed with a combined in-situ UV-vis/XAFS spectroscopic setup.

  2005cited by this paper
• Methylation of the Imidazole Side Chains of the Alzheimer Disease Amyloid-β Peptide Results in Abolition of Superoxide Dismutase-like Structures and Inhibition of Neurotoxicity*

  2005cited by this paper
• N-Terminal deletions modify the Cu2+ binding site in amyloid-beta.

  2005influential reference
• In situ characterization and mapping of iron compounds in Alzheimer's disease tissue

  2005cited by this paper
• Structure of the cross-β spine of amyloid-like fibrils

  2005influential reference
• Amyloid-β Binds Cu2+ in a Mononuclear Metal Ion Binding Site

  2004influential reference
• Copper binding to the amyloid-beta (Abeta) peptide associated with Alzheimer's disease: folding, coordination geometry, pH dependence, stoichiometry, and affinity of Abeta-(1-28): insights from a range of complementary spectroscopic techniques.

  2004influential reference
• Copper Binding to the Amyloid-β (Aβ) Peptide Associated with Alzheimer's Disease

  2004influential reference
• Beta-amyloid protein oligomers induced by metal ions and acid pH are distinct from those generated by slow spontaneous ageing at neutral pH.

  2003influential reference
• Coordination abilities of the 1-16 and 1-28 fragments of beta-amyloid peptide towards copper(II) ions: a combined potentiometric and spectroscopic study.

  2003influential reference
• Metal Ions, pH, and Cholesterol Regulate the Interactions of Alzheimer's Disease Amyloid-β Peptide with Membrane Lipid*

  2003influential reference
• Metal switch for amyloid formation: insight into the structure of the nucleus.

  2002cited by this paper
• Metalloenzyme-like Activity of Alzheimer's Disease β-Amyloid

  2002cited by this paper
• A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR.

  2002cited by this paper
• Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2).

  2002influential reference
• Alzheimer's Disease Amyloid-β Binds Copper and Zinc to Generate an Allosterically Ordered Membrane-penetrating Structure Containing Superoxide Dismutase-like Subunits*

  2001influential reference
• Metal binding modes of Alzheimer's amyloid beta-peptide in insoluble aggregates and soluble complexes.

  2000influential reference
• 3D EXAFS refinement of the Cu site of azurin sheds light on the nature of structural change at the metal centre in an oxidation-reduction process: an integrated approach combining EXAFS and crystallography.

  2000cited by this paper
• Metals and neuroscience.

  2000cited by this paper
• Characterization of Copper Interactions with Alzheimer Amyloid β Peptides

  2000influential reference
• Zinc-induced Alzheimer’s Aβ1–40 Aggregation Is Mediated by Conformational Factors*

  1997cited by this paper

• A critical review of amyloid fibrils composites as emerging materials for the removal of metal ions from water: Synthesis, characteristics, removal performance and mechanism

  2025cites this paper
• His6, His13, and His14 residues in Aβ 1–40 peptide significantly and specifically affect oligomeric equilibria

  2019cites this paper
• The mechanism of action of clioquinol for the treatment of Alzheimer's disease

  2018cites this paper
• Conformational Transitions of the Amyloid‐β Peptide Upon Copper(II) Binding and pH Changes

  2017cites this paper
• Penta-glycine copper(II) complexes in slightly alkaline solutions

  2016cites this paper
• Copper Ion Binding Site in β-Amyloid Peptide.

  2016cites this paper
• In-vivo and in-vitro techniques used to investigate Alzheimer's disease

  2015cites this paper
• Use of a new water-soluble Zn sensor to determine Zn affinity for the amyloid-β peptide and relevant mutants.

  2014cites this paper
• Single-Molecule Imaging of Amyloid-β Protein (Aβ) of Alzheimer’s Disease: From Single-Molecule Structures to Aggregation Mechanisms and Membrane Interactions

  2014cites this paper
• 3D structures and redox potentials of Cu2+-Aβ(1-16) complexes at different pH: a computational study.

  2014cites this paper
• Amyloid-β peptide active site: theoretical Cu K-edge XANES study

  2013cites this paper
• Copper and oxidative stress in the pathogenesis of Alzheimer's disease.

  2012cites this paper
• Nanomechanics of functional and pathological amyloid materials.

  2011cites this paper
• Oxidative stress and cell membranes in the pathogenesis of Alzheimer's disease.

  2011cites this paper
• Oligomerization, Degradation and Aggregation Reactions and Products of Synuclein Polypeptides Related to Parkinson’s Disease

  2011cites this paper
• Crystal Structure of the Amyloid-β p3 Fragment Provides a Model for Oligomer Formation in Alzheimer's Disease

  2011cites this paper
• CrystalStructureoftheAmyloid-p3FragmentProvidesa ModelforOligomerFormationinAlzheimer'sDisease

  2011cites this paper
• Three dimensional models of Cu(2+)-Aβ(1-16) complexes from computational approaches.

  2011cites this paper
• Amyloids and Protein Aggregation-Analytical Methods

  2009cites this paper
• Amyloid plaques in PSAPP mice bind less metal than plaques in human Alzheimer's disease

  2009influential citation
• Pharmacotherapeutic targets in Alzheimer's disease

  2008cites this paper
• The structure of the amyloid-beta peptide high-affinity copper II binding site in Alzheimer disease.

  2008cites this paper
• Substrate mediated reduction of copper-amyloid-beta complex in Alzheimer's disease.

  2008cites this paper